Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 10:29:48 +0200Fri, 05 Jul 2024 14:59:00 +0200Opinion/decision on a Paediatric investigation plan (PIP): Filsuvez, birch bark, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0243/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001299-pip03-17-m02Opinion/decision on a Paediatric investigation plan (PIP): Filsuvez, birch bark, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0243/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001299-pip03-17-m02Fri, 05 Jul 2024 14:59:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Filsuvez, birch bark extract, Date of authorisation: 21/06/2022, Revision: 3, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/filsuvezHuman medicines European public assessment report (EPAR): Filsuvez, birch bark extract, Date of authorisation: 21/06/2022, Revision: 3, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/filsuvezTue, 30 Jan 2024 08:30:00 +0100Human medicineFilsuvez : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5035-en.pdfFilsuvez : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5035-en.pdfMon, 29 Jan 2024 12:30:00 +0100Human medicine